| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Nuclear Receptor Discovery Ligand Pharmaceuticals, Inc. San Diego, California 92121
Binding of agonists to nuclear receptors results
in a conformational change in receptor structure that promotes
interaction between activated receptors and coactivators.
Receptor-coactivator interactions are mediated by the agonist-dependent
formation of a hydrophobic pocket on the part of
receptors, and short leucine-rich sequences termed LxxLL motifs or
nuclear receptor boxes present in coactivators. RXR-PPAR
(retinoid X
receptor-peroxisome proliferator-activated receptor-
) heterodimers
play important roles in adipocyte and macrophage differentiation and
have been implicated as therapeutic targets in diabetes,
atherosclerosis, and cancer. Analysis of interactions between
RXR-PPAR
heterodimers and coactivator nuclear receptor boxes
suggests that RXR and PPAR
can distinguish among coactivators by
recognizing distinct structural features of nuclear receptor boxes. The
results also indicate that coactivator choice by RXR is mediated by
three nonconserved amino acids of the nuclear receptor box. The ability
of an optimized seven-amino acid nuclear receptor box to specifically
interact with RXR and function as a selective inhibitor suggests the
coactivator-binding pocket may serve as a new target for drug
discovery.
This article has been cited by other articles:
![]() |
M. G. Rosenfeld, V. V. Lunyak, and C. K. Glass Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response Genes & Dev., June 1, 2006; 20(11): 1405 - 1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. C. Klein, R. A. Atkinson, N. Potier, D. Moras, and J. Cavarelli Biochemical and NMR Mapping of the Interface between CREB-binding Protein and Ligand Binding Domains of Nuclear Receptor: BEYOND THE LXXLL MOTIF J. Biol. Chem., February 18, 2005; 280(7): 5682 - 5692. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Fox, P. Brown, C. Han, S. Ashe, R. D. Leek, A. L. Harris, and A. H. Banham Expression of the Forkhead Transcription Factor FOXP1 Is Associated with Estrogen Receptor {alpha} and Improved Survival in Primary Human Breast Carcinomas Clin. Cancer Res., May 15, 2004; 10(10): 3521 - 3527. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Osburn, G. Shao, H. M. Seidel, and I. G. Schulman Ligand-Dependent Degradation of Retinoid X Receptors Does Not Require Transcriptional Activity or Coactivator Interactions Mol. Cell. Biol., August 1, 2001; 21(15): 4909 - 4918. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Heery, S. Hoare, S. Hussain, M. G. Parker, and H. Sheppard Core LXXLL Motif Sequences in CREB-binding Protein, SRC1, and RIP140 Define Affinity and Selectivity for Steroid and Retinoid Receptors J. Biol. Chem., February 23, 2001; 276(9): 6695 - 6702. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |